SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535610-19-000041
Filing Date
2019-01-07
Accepted
2019-01-07 09:01:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G-A ORMP 1.07.19 ormp0119.txt SC 13G/A 11708
  Complete submission text file 0001535610-19-000041.txt   13440
Mailing Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019 646-844-1164
ORAMED PHARMACEUTICALS INC. (Subject) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: SC 13G/A | Act: 34 | File No.: 005-79895 | Film No.: 19512349
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A